- $85.38bn
- $126.87bn
- $64.97bn
- 92
- 54
- 97
- 95
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 15.15 | ||
| PEG Ratio (f) | 1.73 | ||
| EPS Growth (f) | 9.58% | ||
| Dividend Yield (f) | 0.8% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 18.22 | ||
| Price to Sales | 1.31 | ||
| EV to EBITDA | 9.99 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 22.1% | ||
| Return on Equity | n/a | ||
| Operating Margin | 14.82% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 51,336 | 51,533 | 58,752 | 60,233 | 64,968 | 69,119.28 | 72,835.88 | 6.84% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +27.17 | +10.78 | +48.84 | -8.51 | +19.78 | +8.53 | +12.02 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
HCA Healthcare, Inc. is a health care services company. The Company owns, manages or operates hospitals, freestanding surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, physician practices, home health, hospice, outpatient physical therapy home and community-based services providers, and various other facilities. It also operates outpatient health care facilities, which include freestanding ambulatory surgery centers (ASCs), freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, comprehensive rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices and other facilities. It operates about 186 hospitals, comprised of 178 general, acute care hospitals, six behavioral hospitals and two rehabilitation hospitals.
Directors
- Thomas Frist CHM (53)
- Samuel Hazen CEO (60)
- William Rutherford CFO (57)
- Jon Foster CEX (59)
- Charles Hall CEX (67)
- Arnold Moore CEX (60)
- Jennifer Berres CHO (50)
- Michael Cuffe EVP (55)
- J. William Morrow SVF (51)
- Paul Paslick SVP (61)
- Kathleen Whalen SVP (57)
- Robert Waterman SVP (67)
- Christopher Wyatt SVP (43)
- Deborah Reiner SVP (59)
- Phillip Billington SVP (53)
- Jeff Cohen SVP (49)
- Jane Englebright SVP (63)
- Michael McAlevey SVP
- Sandra Morgan SVP (58)
- Joseph Sowell SVP (64)
- Kathryn Torres SVP (57)
- William Frist DRC (51)
- Meg Crofton IND (67)
- Robert Dennis IND (67)
- Nancy-ann Deparle IND (64)
- Charles Holliday IND (73)
- Hugh Johnston IND (60)
- Michael Michelson IND (69)
- Wayne Riley IND (61)
- Andrea Smith IND (54)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- October 19th, 2010
- Public Since
- December 28th, 2010
- No. of Shareholders
- 420
- No. of Employees
- 220,000
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
New York Stock Exchange- Shares in Issue
- 264,485,460
- Address
- 1 Park Plz, NASHVILLE, 37203-6527
- Web
- https://hcahealthcare.com/
- Phone
- +1 6153449551
- Contact
- Frank Morgan
- Auditors
- Ernst & Young LLP
Upcoming Events for HCA
HCA Healthcare Inc Annual Shareholders Meeting
Q1 2024 HCA Healthcare Inc Earnings Release
Q1 2024 HCA Healthcare Inc Earnings Call
HCA Healthcare Inc at Bank of America Health Care Conference
HCA Healthcare Inc at Leerink Partners Healthcare Crossroads Conference
HCA Healthcare Inc at Sanford C Bernstein Strategic Decisions Conference
Q2 2024 HCA Healthcare Inc Earnings Release
Similar to HCA
Agilon Health
New York Stock Exchange
AMERICAN WELL
New York Stock Exchange
AMN Healthcare Services
New York Stock Exchange
Ati Physical Therapy
New York Stock Exchange
Auna SAA
New York Stock Exchange
FAQ
What is the HCA Healthcare share price?
As of Today at 19:10 UTC, shares in HCA Healthcare are trading at $322.82. This share price information is delayed by 15 minutes.
How has the HCA Healthcare share price performed this year?
Shares in HCA Healthcare last closed at $322.82 and the price had moved by +18.07% over the past 365 days. In terms of relative price strength the HCA Healthcare share price has underperformed the S&P500 Index by -4.65% over the past year.
What are the analyst and broker recommendations for HCA Healthcare?
The overall consensus recommendation for HCA Healthcare is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the HCA Healthcare dividend yield?
The HCA Healthcare dividend yield is 0.74% based on the trailing twelve month period.
Does HCA Healthcare pay a dividend?
Last year, HCA Healthcare paid a total dividend of $2.40, and it currently has a trailing dividend yield of 0.74%. We do not have any data on when HCA Healthcare is to next pay dividends.
When does HCA Healthcare next pay dividends?
We do not have data on when HCA Healthcare is to next pay dividends. The historic dividend yield on HCA Healthcare shares is currently 0.74%.
How do I buy HCA Healthcare shares?
To buy shares in HCA Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of HCA Healthcare?
As of the previous close price of $322.82, shares in HCA Healthcare had a market capitalisation of $85.38bn.
Where are HCA Healthcare shares listed?
Here are the trading details for HCA Healthcare:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: HCA
What kind of share is HCA Healthcare?
Based on an overall assessment of its quality, value and momentum HCA Healthcare is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a HCA Healthcare share price forecast for 2024?
The analyst consensus target price for shares in HCA Healthcare is $337.32. That is 4.49% above the last closing price of $322.82.
Analysts covering HCA Healthcare currently have a consensus Earnings Per Share (EPS) forecast of $20.60 for the next financial year.
What is the trend in the HCA Healthcare share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like HCA Healthcare. Over the past six months, its share price has outperformed the S&P500 Index by +16.07%.
As of the last closing price of $322.82, shares in HCA Healthcare were trading +16.05% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the HCA Healthcare PE Ratio?
The HCA Healthcare PE ratio based on its reported earnings over the past 12 months is 15.15. The shares last closed at $322.82.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of HCA Healthcare?
HCA Healthcare's management team is headed by:
- Thomas Frist - CHM
- Samuel Hazen - CEO
- William Rutherford - CFO
- Jon Foster - CEX
- Charles Hall - CEX
- Arnold Moore - CEX
- Jennifer Berres - CHO
- Michael Cuffe - EVP
- J. William Morrow - SVF
- Paul Paslick - SVP
- Kathleen Whalen - SVP
- Robert Waterman - SVP
- Christopher Wyatt - SVP
- Deborah Reiner - SVP
- Phillip Billington - SVP
- Jeff Cohen - SVP
- Jane Englebright - SVP
- Michael McAlevey - SVP
- Sandra Morgan - SVP
- Joseph Sowell - SVP
- Kathryn Torres - SVP
- William Frist - DRC
- Meg Crofton - IND
- Robert Dennis - IND
- Nancy-ann Deparle - IND
- Charles Holliday - IND
- Hugh Johnston - IND
- Michael Michelson - IND
- Wayne Riley - IND
- Andrea Smith - IND